Alcon Expands Its Cell Therapy Ambitions With $550M Neurotech Pharma Acquisition
Alcon’s Neurotech Prescribed drugs acquisition brings the uncommon imaginative and prescient dysfunction cell remedy Encelto in addition to the platform ...
Alcon’s Neurotech Prescribed drugs acquisition brings the uncommon imaginative and prescient dysfunction cell remedy Encelto in addition to the platform ...
Shionogi’s IntraBio acquisition brings Aqneursa, a drug accepted for treating two uncommon neurological issues and the potential to broaden to ...
Jazz Prescription drugs, maker of the blockbuster epilepsy drug Epidiolex, is buying Actio Biosciences and its lead drug in pivotal ...
With the merger, Processa’s new lead asset is a Vidya Therapeutics immunology drug that provides pipeline-in-a-product potential addressing a goal ...
Eli Lilly’s AtaiBeckley acquisition marks a dozen M&A offers for the pharma firm up to now this 12 months. AtaiBeckley’s ...
Myricx Bio brings to Novartis antibody drug conjugates with a novel cancer-killing payload referred to as an NMT inhibitor. Novartis ...
Apogee Therapeutics brings AbbVie a long-acting antibody prepared for Part 3 testing in atopic dermatitis, additionally known as eczema. This ...
GSK’s oncology technique had targeted on gynecological and blood cancers, however the pharmaceutical firm is putting offers that broaden its ...
KalVista Prescription drugs brings to Chiesi Group the product Ekterly, the primary FDA-approved oral drug for acute remedy of swelling ...
Within the newest episode of the Debunked podcast, MedCity Information Editor-in-Chief Arundhati Parmar and Samir Batra, Managing Companion of Well ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.